Home›Search›Human Psychopharmacology

Human Psychopharmacology

John Wiley and Sons Ltd · United Kingdom · Est. 1986

ISSN1099-1077

SJR Q3✓ WOS SCIE✓ Scopus / SJR

/ 100

High Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q3+12

Total37

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.51

H-Index

102

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.589

Total Works

3,580

Total Citations

66,222

2yr Mean Citedness

0.92

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Compiled from public sources

Human Psychopharmacology: Clinical and Experimental is a psychopharmacology journal that publishes clinical and experimental research on new and established psychotropic medicines. It considers experimental studies of centrally active drugs, including herbal products, in clinical, social, and psychological contexts, as well as papers on drugs of abuse and drug dependency. The journal also welcomes animal studies relevant to human psychopharmacology.

AI-compiled from public web sources · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 75% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1986

Annual Volume~ 35 articles / year

StatusActive (last: 2026)

Total Publications3,580

Publisher OrgWiley

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

John Wiley and Sons Ltd

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1099-1077

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

NeurologyQ3

Neurology (clinical)Q3

Pharmacology (medical)Q3

Psychiatry and Mental HealthQ3

Subject Classification

Web of Science Categories

Clinical NeurologyPharmacology & PharmacyPsychiatryPsychology

Scopus Categories

Pharmacology (medical)Neurology (clinical)Psychiatry and Mental HealthNeurology

Research Topics (OpenAlex)

Treatment of Major DepressionSchizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorAttention Deficit Hyperactivity DisorderAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesBipolar Disorder and TreatmentTryptophan and brain disordersElectroconvulsive Therapy StudiesForensic Toxicology and Drug AnalysisSleep and related disorders